Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Joan M, Quigley"'
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 45(10)
Simeprevir (SMV) is an oral, once-daily protease inhibitor for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection. In phase II/III randomized controlled trials (RCT) conducted in Japan, SMV, in combination with peginterferon-α and